MEFV Mutation Carriers and Diseases Other than Familial Mediterranean Fever: Proved and Non-Proved Associations; Putative Biological Advantage

Publisher： Bentham Science Publishers

E-ISSN： 1875-5933|4|1|105-112

ISSN： 1568-010X

Source： Current Drug Targets. Inflammation & Allergy, Vol.4, Iss.1, 2005-01, pp. : 105-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biological Agents in Familial Mediterranean Fever Focusing on Colchicine Resistance and Amyloidosis

By  

Current Medicinal Chemistry, Vol. 22, Iss. 16, 2015-05 ,pp. : 1986-1991

Bentham Science Publishers

Access to resources Recommend Favorite

QT Dispersion is Not Increased in Familial Mediterranean Fever

By Topal F   Tanindi A   Kurtoglu HG   Akbulut S   Kucukazman M   Topal FE  

The Journal of International Medical Research, Vol. 39, Iss. 5, 2011-09 ,pp. : 2006-2011

Field House Publishing

Access to resources Recommend Favorite

Ankylosing Spondylitis Among Familial Mediterranean Fever Patients

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 2, 2018-02 ,pp. : 148-154

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological and Clinical Basis of Treatment of Familial Mediterranean Fever (FMF) with Colchicine or Analogues: An Update

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 1, 2005-02 ,pp. : 117-124

Bentham Science Publishers

Access to resources Recommend Favorite

Neutrophil F-actin Dynamics in Familial Mediterranean Fever: The Unequal Effect of Colchicine on Activated Neutrophils

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 12, Iss. 2, 2013-08 ,pp. : 165-172

Bentham Science Publishers

Access to resources Recommend Favorite